BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24767860)

  • 21. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney.
    Aydin H; Chen L; Cheng L; Vaziri S; He H; Ganapathi R; Delahunt B; Magi-Galluzzi C; Zhou M
    Am J Surg Pathol; 2010 Nov; 34(11):1608-21. PubMed ID: 20924276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.
    Kuthi L; Jenei A; Hajdu A; Németh I; Varga Z; Bajory Z; Pajor L; Iványi B
    Pathol Oncol Res; 2017 Jul; 23(3):689-698. PubMed ID: 28032311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population.
    Breda A; Lucarelli G; Rodriguez-Faba O; Guirado L; Facundo C; Bettocchi C; Gesualdo L; Castellano G; Grandaliano G; Battaglia M; Palou J; Ditonno P; Villavicencio H
    World J Urol; 2015 Jan; 33(1):1-7. PubMed ID: 24504760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma.
    Zhou H; Zheng S; Truong LD; Ro JY; Ayala AG; Shen SS
    Hum Pathol; 2014 Jan; 45(1):59-64. PubMed ID: 24182559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A study of papillary renal cell carcinoma. Clinicopathological, immunohistochemical features and its typing].
    Ono Y; Ito T; Tsujino S; Aizawa S; Suzuki M
    Nihon Hinyokika Gakkai Zasshi; 1997 Jun; 88(6):587-95. PubMed ID: 9234615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathologic and clinical characteristics of early onset renal cell carcinoma.
    Clemmensen T; Matoso A; Graham T; Lai WS; Rais-Bahrami S; Gordetsky J
    Hum Pathol; 2018 Apr; 74():25-31. PubMed ID: 29133143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contemporary Characterization and Recategorization of Adult Unclassified Renal Cell Carcinoma.
    Kwon R; Argani P; Epstein JI; Lombardo KA; Wang X; Pierorazio PM; Mehra R; Matoso A
    Am J Surg Pathol; 2021 Apr; 45(4):450-462. PubMed ID: 33239504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solid variants of papillary (chromophil) renal cell carcinoma: clinicopathologic and genetic features.
    Renshaw AA; Zhang H; Corless CL; Fletcher JA; Pins MR
    Am J Surg Pathol; 1997 Oct; 21(10):1203-9. PubMed ID: 9331293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clear cell papillary renal cell carcinoma: a review.
    Kuroda N; Ohe C; Kawakami F; Mikami S; Furuya M; Matsuura K; Moriyama M; Nagashima Y; Zhou M; Petersson F; López JI; Hes O; Michal M; Amin MB
    Int J Clin Exp Pathol; 2014; 7(11):7312-8. PubMed ID: 25550767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of subtypes of metastatic renal-cell carcinoma: correlating findings of fine-needle aspiration biopsy and surgical pathology.
    Mai KT; Alhalouly T; Lamba M; Yazdi HM; Stinson WA
    Diagn Cytopathol; 2003 Feb; 28(2):66-70. PubMed ID: 12561022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma.
    Ohe C; Smith SC; Sirohi D; Divatia M; de Peralta-Venturina M; Paner GP; Agaimy A; Amin MB; Argani P; Chen YB; Cheng L; Colecchia M; Compérat E; Werneck da Cunha I; Epstein JI; Gill AJ; Hes O; Hirsch MS; Jochum W; Kunju LP; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Nesi G; Osunkoya AO; Picken MM; Rao P; Reuter VE; de Oliveira Salles PG; Schultz L; Tickoo SK; Tomlins SA; Trpkov K; Amin MB
    Am J Surg Pathol; 2018 Mar; 42(3):279-292. PubMed ID: 29309300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquired Cystic Disease-associated Renal Cell Carcinoma (ACD-RCC): A Multiinstitutional Study of 40 Cases With Clinical Follow-up.
    Przybycin CG; Harper HL; Reynolds JP; Magi-Galluzzi C; Nguyen JK; Wu A; Sangoi AR; Liu PS; Umar S; Mehra R; Zhang X; Cox RM; McKenney JK
    Am J Surg Pathol; 2018 Sep; 42(9):1156-1165. PubMed ID: 29851703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
    Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
    Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.
    Tickoo SK; dePeralta-Venturina MN; Harik LR; Worcester HD; Salama ME; Young AN; Moch H; Amin MB
    Am J Surg Pathol; 2006 Feb; 30(2):141-53. PubMed ID: 16434887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The MIB-1 tumor proliferation index in adult renal epithelial tumors with granular cytoplasm: biologic implications and differential diagnostic potential.
    Tickoo SK; Amin MB; Linden MD; Zarbo RJ
    Mod Pathol; 1998 Nov; 11(11):1115-21. PubMed ID: 9831210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features.
    Kunju LP; Wojno K; Wolf JS; Cheng L; Shah RB
    Hum Pathol; 2008 Jan; 39(1):96-101. PubMed ID: 17949780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome.
    Massari F; Ciccarese C; Hes O; Michal M; Caliò A; Fiorentino M; Giunchi F; D'Amuri A; Sanguedolce F; Sabbatini R; Guida A; Ardizzoni A; Porta C; Iacovelli R; Tortora G; Cima L; Ortega C; Lapini A; Martignoni G; Brunelli M
    Pathol Oncol Res; 2018 Jul; 24(3):447-456. PubMed ID: 28695322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Papillary renal cell carcinoma: clinical implication of DNA content analysis.
    el-Naggar AK; Ro JY; Ensign LG
    Hum Pathol; 1993 Mar; 24(3):316-21. PubMed ID: 8454276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.